Publications The impact of treat to target on 1 year real world outcomes in patients with rheumatoid arthritis
Publications The profile and secondary care management of UK patients with Hidradenitis Suppurativa: Interim results from a multicentre observational cross-sectional study
Publications Structured transition enhances clinical outcome without an increase in healthcare cost in adolescent patients with IBD: The UK TRANSIT Study
Publications Real world use of adalimumab in UK patients with ulcerative colitis: an observational retrospective study
Publications Real world use of adalimumab: effects on corticosteroid treatment and hospital resource utilisation in UK patients with moderate/severe ulcerative colitis
Publications Hospital resource use and cost associated with first-line anti-TNF therapy in patients with inflammatory bowel disease in the UK: comparison of subcutaneous (adalimumab) and intravenous (infliximab) therapies
Publications The impact of transition to adult gastroenterology services on health-related quality of life in young adult patients with Inflammatory Bowel Disease (IBD): The UK TRANSIT study
Publications Resource use associated with the management of docetaxel-related haematological toxicities, including neutropenic sepsis (NS), in patients with advanced non-small cell lung cancer (NSCLC) in the UK NHS: REVEAL-NS
Publications The rate of neutropenic sepsis (NS) and other haematological toxicities in patients with advanced non-small cell lung cancer (NSCLC) treated with docetaxel in the UK NHS: REVEAL-NS
Publications A retrospective United Kingdom (UK) chart review of early Vedolizumab experience: Real-World treatment, effectiveness and safety in inflammatory Bowel Disease (REVIVE)